Average Insider

Where insiders trade, we follow

$MAIA
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Healthcare
Sector
Biotechnology
Industry
Vlad Vitoc
CEO
13
Employees
$1.30
Current Price
$77.03M
Market Cap
52W Low$0.87
Current$1.3018.5% above low, 81.5% below high
52W High$3.19

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys15$202,790.95147,483All Buys
Sells00--
2 monthsBuys15$202,790.95147,483All Buys
Sells00--
3 monthsBuys15$202,790.95147,483All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Aug 26, 2026
Guerrero Ramiro
Director
Purchase8,931$1.39$12,414.09View Details
Aug 27, 2026
Guerrero Ramiro
Director
Purchase78,239$1.39$108,752.21View Details
Aug 28, 2026
Guerrero Ramiro
Director
Purchase46,620$1.35$62,937.00View Details
Aug 24, 2026
Guerrero Ramiro
Director
Purchase1,794$1.33$2,386.02View Details
Aug 20, 2026
Guerrero Ramiro
Director
Purchase11,899$1.37$16,301.63View Details
21 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.7.3